Holen Sie sich die Stockscreener-App
1.16
1.69%
-0.02
Handel nachbörslich:
1.18
0.02
+1.72%
Actinium Pharmaceuticals Inc Aktie (ATNM) Neueste Nachrichten
ATNM Should I Buy - Intellectia AI
Actinium (ATNM) Delivers Q1 2026 Beat — EPS $-0.18 vs $-0.24 ExpectedMost Discussed Stocks - Newser
Actinium (ATNM) Falls -2.34% — Watching $1.19 Support 2026-05-15Viral Trade Signals - newser.com
ATNM Stock Price, Quote & Chart | ACTINIUM PHARMACEUTICALS INC (NYSEARCA:ATNM) - ChartMill
TradingKey - TradingKey
MSN Money - MSN
Actinium: Q1 Earnings Snapshot - kare11.com
[10-Q] Actinium Pharmaceuticals, Inc. Quarterly Earnings Report - Stock Titan
Actinium Pharmaceuticals Inc. (ATNM) Stock Price | Live Quotes & Charts | AMEX - StocksToTrade
Actinium Pharmaceuticals Announces Three SNMMI 2026 Presentations Highlighting Differentiated Profile of ATNM-400 Across Lung and Prostate Cancer and Radioconjugate Optimization - Barchart.com
Actinium presents preclinical data on AML drug at AACR meeting By Investing.com - Investing.com India
Actinium Pharmaceuticals (ATNM) Unveils Promising Preclinical Fi - GuruFocus
Actinium Pharmaceuticals (ATNM) Presents Promising Data on Actim - GuruFocus
Actinium presents preclinical data on AML drug at AACR meeting - Investing.com
Actinium Pharmaceuticals presents preclinical data for ATNM-400 - Investing.com
Actinium Pharmaceuticals presents preclinical data for ATNM-400 By Investing.com - Investing.com South Africa
Dr. Electric Explains What Colorado Springs Homeowners Should Check Before Summer Electrical Demand Peaks - Weekly Voice
Actinium Pharmaceuticals, Inc. Announces Compelling Pan-Tumor Data for ATNM-400 Demonstrating Broad Efficacy Across Prostate, Lung, and Breast Cancer Models at the 2026 American Association of Cancer Research Annual Meeting - PR Newswire
SDEV Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Actinium Highlights Transcriptional Reprogramming as a Key Mechanism Underpinning Mutation-Agnostic Activity of Actimab-A in AML at the 2026 American Association of Cancer Research Annual Meeting - PR Newswire
Targeted Alpha Therapy Market Landscape Report 2026-2030: Clinical Trials Insights on 30 Drugs - GlobeNewswire Inc.
Actinium (ATNM) Stock: Is It a Strong Buy? (+4.00%) 2026-04-18AI Powered Stock Picks - Cổng thông tin điện tử tỉnh Lào Cai
ATNM Actinium Pharmaceuticals Inc. (Delaware) gains four percent after Q4 2025 results despite slight EPS miss against analyst expectations.Consensus Forecast - Newser
What are analysts saying about Actinium (ATNM) Stock | Price at $1.07, Down 0.93%Expert Stock Picks - newser.com
Aug Macro: Is now the right time to enter Actinium Pharmaceuticals Inc2026 Earnings & Fast Exit and Entry Trade Guides - baoquankhu1.vn
Actinium Pharma unveils groundbreaking data on radiotherapy platform at AACR 2026 - Indian Pharma Post
Aug Highlights: Can Actinium Pharmaceuticals Inc outperform in the next rallyJobs Report & Consistent Profit Trade Alerts - baoquankhu1.vn
Support Test: Is Actinium Pharmaceuticals Inc subject to activist investor interest2026 Weekly Recap & Target Return Focused Picks - baoquankhu1.vn
ATNM Q4 2025 Earnings: Actinium Pharma misses EPS, reports zero revenueForward Guidance Trends - Newser
Actinium Pharmaceuticals Announces New Pan-Tumor Preclinical Data for ATNM-400 in Solid Tumors and Differentiated Mechanism for Actimab-A in AML to be Presented at 2026 AACR Annual Meeting - The AI Journal
Actinium Pharmaceuticals Announces New Pan-Tumor Preclinical Data for ATNM-400 in Solid Tumors and Differentiated Mechanism for Actimab-A in AML to be Presented at 2026 AACR Annual Meeting – Company AnnouncementFT.com - Financial Times
Aug Mood: Can Actinium Pharmaceuticals Inc outperform in the next rallyWeekly Market Summary & Detailed Earnings Play Strategies - baoquankhu1.vn
What is HC Wainwright’s Estimate for ATNM FY2026 Earnings? - Defense World
ATNM Shareholders Have Opportunity to Lead Actinium Pharmaceutica - The National Law Review
Research Analysts Set Expectations for ATNM Q1 Earnings - Defense World
Actinium Pharmaceuticals (NYSE:ATNM) Receives “Overweight” Rating from Stephens - Defense World
ATNM: Stephens & Co. Reiterates Overweight Rating with $5.00 Tar - GuruFocus
Actinium Pharmaceuticals 2026 Annual Report: Clinical-Stage Radiopharmaceutical Innovations, Competitive Strengths, and Regulatory Risk Factors - Minichart
Actinium: Q4 Earnings Snapshot - KVUE
Actinium Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Actinium Pharmaceuticals (NYSE: ATNM) outlines radiotherapy pipeline, losses and 2026 manufacturing plans - Stock Titan
Actinium Pharmaceuticals (ATNM) Eps Diluted (TTM) - Zacks Investment Research
Portfolio Shifts: What is the dividend yield of Actinium Pharmaceuticals Inc2026 Market Overview & Weekly High Return Stock Forecasts - baoquankhu1.vn
Actinium Pharmaceuticals (ATNM) board adopts annual Say-on-Pay advisory votes - Stock Titan
Comparing UCB (OTCMKTS:UCBJF) and Actinium Pharmaceuticals (NYSE:ATNM) - Defense World
Fundamentals Check: Is Actinium Pharmaceuticals Inc undervalued by DCF analysis - baoquankhu1.vn
If You Invested $1,000 in Actinium Pharmac (ATNM) - Stock Titan
Stop Loss: What is the next catalyst for Actinium Pharmaceuticals IncCEO Change & Reliable Breakout Forecasts - baoquankhu1.vn
Alpha Emitter Market Size, Share & Growth Graph by 2034 - Straits Research
Analysis Recap: Is Actinium Pharmaceuticals Inc stock good for income investors2026 Market Mood & Fast Entry and Exit Trade Plans - baoquankhu1.vn
Wall Street Recap: Is Actinium Pharmaceuticals Inc stock trending bullishInflation Watch & Reliable Intraday Trade Alerts - baoquankhu1.vn
IPO Launch: Can Actinium Pharmaceuticals Inc stock double in the next year2026 Short Interest & High Yield Equity Trading Tips - baoquankhu1.vn
Aug Shorts: What is the dividend yield of Actinium Pharmaceuticals Inc2025 Investor Takeaways & Technical Pattern Alert System - baoquankhu1.vn
Market Rankings: Is Actinium Pharmaceuticals Inc undervalued by DCF analysisJuly 2025 Levels & AI Forecast Swing Trade Picks - baoquankhu1.vn
Why Is Actinium Pharmaceuticals Stock Rising Today? - Stocktwits
Analysis Recap: Can Actinium Pharmaceuticals Inc outperform in the next rallyJuly 2025 Retail & AI Enhanced Execution Alerts - baoquankhu1.vn
0.98%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):